Reliance Industries reported a 2% beat in Q4 PAT, though EPS estimates were cut by 2% due to O2C and retail weakness caused by Iran-related volatility. CLSA maintains an 'Outperform' rating with a target of ₹1,800, citing FMCG strength and upcoming energy capacities as primary catalysts.
Market snapshot: Reliance Industries (RIL) reported a resilient Q4 performance with a 2% beat in Profit After Tax (PAT), navigating significant headwinds in its O2C and retail segments. While external geopolitical tensions led to a slight downward revision in earnings estimates, the long-term growth narrative remains anchored by the expansion of the New Energy and FMCG businesses.
Summary: Reliance Industries reported a 2% beat in Q4 PAT, though EPS estimates were cut by 2% due to O2C and retail weakness caused by Iran-related volatility. CLSA maintains an 'Outperform' rating with a target of ₹1,800, citing FMCG strength and upcoming energy capacities as primary catalysts.
Reliance Industries is currently undergoing a structural transition. While the legacy O2C business remains susceptible to energy market volatility—evidenced by the 2% EPS cut—the robust 2% PAT beat reflects the strength of its diversified portfolio. Investors should focus on the 'J-curve' potential of the New Energy segment, which is expected to balance the cyclicality of the retail and energy arms.
The market impact is expected to be neutral to slightly positive as the PAT beat counteracts the EPS revision. For sector allocation, the shift toward Media and FMCG suggests RIL is positioning itself as a domestic consumption giant, reducing its sensitivity to global crude spreads over time.
Market Bias: Neutral
The 2% PAT beat is balanced by a 2% EPS cut, suggesting a period of consolidation. The bias remains neutral until O2C margins stabilize from Iran-led volatility.
Overweight: FMCG, Renewable Energy, Media
Underweight: Oil to Chemicals (O2C), Global Retail Logistics
Trigger Factors:
Time Horizon: Medium-term (3-12 months)
The global energy sector is currently navigating a period of intense geopolitical risk, specifically in the Middle East. Reliance’s ability to post a PAT beat in this environment distinguishes it from global peers who have struggled with margin compression. Furthermore, the Indian FMCG landscape is seeing a shift toward organized players, where Reliance Retail’s private labels are gaining significant traction.
In the last 60 days, Reliance has accelerated its 'New Energy' pivot, announcing a pilot for green hydrogen production in Gujarat. Additionally, the FMCG arm, 'Independence,' has expanded its distribution to five new states, and Jio has reported a 15% increase in ARPU following the latest 5G monetization phase.
Reliance Industries remains a quintessential proxy for the Indian economy. While the 2% EPS cut reflects immediate global risks, the underlying 2% PAT beat and aggressive expansion in sunrise sectors like New Energy suggest the long-term value proposition remains intact.
The 2% EPS cut is forward-looking, accounting for the anticipated margin pressure in the O2C segment due to high crude price volatility stemming from Middle East tensions.
The FMCG and Media segments showed the strongest growth, acting as a buffer against the relative weakness in the Retail and O2C divisions.
The target price reflects CLSA's valuation of the company's diversified assets, particularly factoring in the upcoming 2026-2027 revenue streams from new energy giga-factories.
High Performance Trading with SAHI.
Related
JPMorgan Downgrades Apollo Tyres: Navigating Commodity Headwinds and Sector Re-rating
JPMorgan Bullish on TVS Motor: Target Price Hiked to ₹4,440 as Resilience Outshines Sector Risks
JPMorgan Shifts Stance on Escorts Kubota: Upgrade to Neutral Amid Sector Recalibration
Geopolitical Friction in Hormuz: Oil Majors Flag Costs of Proposed Tolls and India’s Readiness Gaps
Recent
Cosmic CRF Q4 Net Profit Surges 128% to ₹26 Crore as Revenue Hits ₹410 Crore
Sigma Advanced System Q4 Net Profit Jumps 634% to ₹130 Cr on Solid Execution
Hitachi Energy Q4 Net Profit Jumps 83% to ₹330 Cr as Revenue Hits ₹2,750 Cr
Orchid Pharma Q4 Net Profit Rises 9.7% to ₹30.6 Cr Despite 15% EBITDA Drop
Nesco Q4 Revenue Surges 30% to ₹250 Cr as IT Park Occupancy Hits 100%